Histone lysine methylation modifiers controlled by protein stability

참고문헌 (131)

1. Hyun, K., "Writing, erasing and reading histone lysine methylations", Exp. Mol. Med, 49, pp.e324~ (2017)
2. Biggar, K. K., "Non-histone protein methylation as a regulator of cellular signalling and function", Nat. Rev. Mol. Cell Biol, 16, pp.5~17 (2015)
3. Cheng, Y., "Targeting epigenetic regulators for cancer therapy : mechanisms and advances in clinical trials", Signal Transduct. Target. Ther, 4, pp.62~ (2019)
4. Hwang, J. Y., "The emerging field of epigenetics in neurodegeneration and neuroprotection", Nat. Rev. Neurosci, 18, pp.347~361 (2017)
5. Wang, N., "Targeting epigenetic regulators to overcome drug resistance in cancers", Signal Transduct. Target. Ther, 8, pp.69~ (2023)
6. Schwartz, A. L., "Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology", Annu. Rev. Pharmacol. Toxicol, 49, pp.73~96 (2009)
7. Nguyen, H. C., "Cullin-RING E3 ubiquitin ligases : bridges to destruction", Subcell Biochem, 83, pp.323~347 (2017)
8. Mevissen, T. E. T., "Mechanisms of deubiquitinase specificity and regulation", Ann. Rev. Biochem, 6, pp.159~192 (2017)
9. Popovic, D., "Ubiquitination in disease pathogenesis and treatment", Nat. Med, 20, pp.1242~1253 (2014)
10. Lange, S. M., "Deubiquitinases: from mechanisms to their inhibition by small molecules", Mol. Cell, 82, pp.15~29 (2022)
11. Clague, M. J., "Breaking the chains: deubiquitylating enzyme specificity begets function", Nat. Rev. Mol. Cell Biol, 20, pp.338~352 (2019)
12. Yang, L., "Histone H3K4 methyltransferases as targets for drug-resistant cancers", Biology, 10, pp.581~ (2021)
13. Lee, J. -E., "H3K4 mono-and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation", eLife, 2, pp.e01503~ (2013)
14. Wang, L. H., "The MLL3", 4 H3K4 methyl transferase complex in establishing an active enhancer landscape, 2021, pp.49, 1041~1054
15. Berkholz, J., "skNAC and Smyd1 in transcrip tional control", Exp. Cell Res, 336, pp.182~191 (2015)
16. Xiao, B., "Structure and catalytic mechanism of the human histone methyltransferase SET7", 9, 2003, pp.421, 652~656
17. Collins, B. E., "Histone H3 lysine K4methylation and its role in learning and memory", Epigenetics Chromatin, 12, pp.7~ (2019)
18. Malagraba, G., "The role of LSD1 and LSD2 in cancers of the gastrointestinal system : an update", Biomolecules, 12, pp.462~ (2022)
19. Sinha, K. M., "Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase", EMBO J, 29, pp.68~79 (2010)
20. Liu, H., "Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution : a critical regulatory circuit lost in leu kemogenic MLL fusions", Genes Dev, 21, pp.2385~2398 (2007)
21. Liu, H., "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", Nature, 467, pp.343~346 (2010)
22. Takeda, S., "Proteolysis of MLL family proteins is essential for taspase1orchestrated cell cycle progression", Genes Dev, 20, pp.2397~2409 (2006)
23. Zhao, Z., "Regulation of MLL", COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia, 2019, pp.33, 61~74
24. Luo, Z., "The super elongation complex(SEC)family in transcriptional control", Nat. Rev. Mol. Cell Biol, 13, pp.543~547 (2012)
25. Saffie, R., "FBXW7 triggers degradation of KMT2D to favor growth of diffuse large B-cell lymphoma cells", Cancer Res, 80, pp.2498~2511 (2020)
26. Morin, R. D., "Frequent mutation of histone-modifying genes in non Hodgkin lymphoma", Nature, 476, pp.298~303 (2011)
27. Zhang, J., "Disruption of KMT2D perturbs germinal center B cell develop ment and promotes lymphomagenesis", Nat. Med, 21, pp.1190~1198 (2015)
28. Shi, Y. J., "Regulation of LSD1 histone demethylase activity by its associated factors", Mol. Cell, 19, pp.857~864 (2005)
29. Han, X., "Destabilizing LSD1 by Jade-2 promotes neurogenesis : an anti braking system in neural development", Mol. Cell, 55, pp.482~494 (2014)
30. Wang, J., "Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties", Cancer Res, 71, pp.7238~7249 (2011)
31. Schulte, J. H., "Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma : implications for therapy", Cancer Res, 69, pp.2065~2071 (2009)
32. Hayami, S., "Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers", Int. J. Cancer, 128, pp.574~586 (2011)
33. Lim, S., "Lysine-specific demethylase 1(LSD1)is highly expressed in ER negative breast cancers and a biomarker predicting aggressive biology", Carci nogenesis, 31, pp.512~520 (2010)
34. Wu, Y., "The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells", Cell Rep, 5, pp.224~236 (2013)
35. Zhou, A., "Nuclear GSK3beta promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22", Nat. Cell Biol, 18, pp.954~966 (2016)
36. Liu, J., "Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer", EMBO Rep, 21, pp.e48597~ (2020)
37. Gong, Z., "OTUD7B deubiquitinates LSD1 to govern its binding partner spe cificity, homeostasis, and breast cancer metastasis", Adv. Sci, 8, pp.e2004504~ (2021)
38. Zalouli, V., "Adult hippocampal neurogenesis(AHN)controls central nervous system and promotes peripheral nervous system regeneration via physical exercise", Biomed. Pharmacother, 165, pp.115078~ (2023)
39. Moreno-Jimenez, E. P., "Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease", Nat. Med, 25, pp.554~560 (2019)
40. Kim, D. K., "Abeta-induced mitochondrial dysfunction in neural progenitors controls KDM5A to influence neuronal differentiation", Exp. Mol. Med, 54, pp.1461~1471 (2022)
41. Li, S., "Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation", Cell Biol. Toxicol, 39, pp.1641~1655 (2023)
42. Xiao, Q., "Regulation of KDM5C stability and enhancer reprogramming in breast cancer", Cell Death Dis, 13, pp.843~ (2022)
43. Brower-Toland, B., "Multiple SET methyltransferases are required to maintain normal hetero chromatin domains in the genome of Drosophila melanogaster", Genetics, 181, pp.1303~1319 (2009)
44. Chen, P. S., "Pathophysiological implications of hypoxia in human diseases", J. Biomed. Sci, 27, pp.63~ (2020)
45. Salminen, A., "Hypoxia-inducible histone lysine demethylases : impact on the aging process and age-related diseases", Aging Dis, 7, pp.180~200 (2016)
46. Chen, H., "Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells", Cancer Res, 66, pp.9009~9016 (2006)
47. Casciello, F., "G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis", Proc. Natl Acad. Sci. USA, 114, pp.7077~7082 (2017)
48. Gossage, L., "VHL, the story of a tumour suppressor gene", Nat. Rev. Cancer, 15, pp.55~64 (2015)
49. Zhang, J., "SPOP mutation induces DNA methylation via stabilizing GLP", G9a, 2021, pp.12, 5716~
50. Markouli, M., "Structure, activity and function of the SETDB1 protein methyltransferase", Life, 11, pp.817~ (2021)
51. Park, S., "Hypoxia stabilizes SETDB1 to maintain genome stability", Nucleic Acids Res, 51, pp.11178~11196 (2023)
52. Zeller, P., "Histone H3K9 methylation is dispensable for Caenorhabditis elegans development but suppresses RNA : DNA hybrid-associated repeat instability", Nat. Genetics, 48, pp.1385~1395 (2016)
53. Chiappinelli, K. B., "Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses", Cell, 162, pp.974~986 (2015)
54. Fukuda, K., "SETDB1-mediated silencing of retroelements", Viruses, 12, pp.596~ (2020)
55. Bao, L., "Methylation of hypoxia-inducible factor(HIF)-1α by G9a", GLP inhi bits HIF-1 transcriptional activity and cell migration, 2018, pp.46, 6576~6591
56. Basavapathruni, A., "Characterization of the enzymatic activity of SETDB1and its 1 : 1 complex with ATF7IP", Biochemistry, 55, pp.1645~1651 (2016)
57. Timms, R. T., "ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex", Cell Rep, 17, pp.653~659 (2016)
58. Tsusaka, T., "The fibronectin type-III(FNIII)domain of ATF7IP contributes to efficient transcriptional silencing mediated by the SETDB1 complex", Epigenetics Chromatin, 13, pp.1~15 (2020)
59. Pappa, S., "PHF2 histone demethylase prevents DNA damage and genome instability by controlling cell cycle progression of neural progenitors", Proc. Natl Acad. Sci. USA, 116, pp.19464~19473 (2019)
60. Black, J. C., "Conserved antagonism between JMJD2A", KDM4A and HP1γduring cell cycle progression, 2010, pp.40, 736~748
61. Tang, H., "Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression", Epigenetics, 18, pp.2192319~ (2023)
62. Yamane, K., "JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor", Cell, 125, pp.483~495 (2006)
63. Okada, Y., "Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis", Nature, 450, pp.119~123 (2007)
64. Cloos, P. A., "The putative oncogene GASC1 demethylates tri-and dime thylated lysine 9 on histone H3", Nature, 442, pp.307~311 (2006)
65. Tsurumi, A., "Drosophila Kdm4 deme thylases in histone H3 lysine 9 demethylation and ecdysteroid signaling", Sci. Rep, 3, pp.2894~ (2013)
66. Van Rechem, C., "The SKP1-Cul1-F-box and leucine-rich repeat protein 4(SCF-FbxL4)ubiquitin ligase regulates lysine demethylase 4A(KDM4A)", Jumonji domain-containing 2A(JMJD2A)protein, 2011, pp.286, 30462~30470
67. Mallette, F. A., "RNF8-and RNF168-dependent degradation of KDM4A", JMJD2A triggers 53BP1 recruitment to DNA damage sites, 2012, pp.31, 1865~1878
68. Lim, H. -J., "The G2", M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20, 2013, pp.33, 4166~4180
69. Wang, Q., "Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis", J. Clin. Invest, 126, pp.2205~2220 (2016)
70. Takahashi, A., "DNA damage signaling triggers degradation of histone methyltransferases through APC", CCdh1 in senescent cells, 2012, pp.45, 123~131
71. Vaquero, A., "SIRT1 regulates the histone methyl-transferase SUV39H1during heterochromatin formation", Nature, 450, pp.440~444 (2007)
72. Bosch-Presegué, L., "Stabilization of Suv39H1 by SirT1 is part of oxida tive stress response and ensures genome protection", Mol. Cell, 42, pp.210~223 (2011)
73. Xu, S., "p300-mediated acetylation of histone demethylase JMJD1A prevents its degradation by ubiquitin ligase STUB1 and enhances its activity in prostate cancer", Cancer Res, 80, pp.3074~3087 (2020)
74. Yu, J. -R., "PRC2 is high main tenance", Genes Dev, 33, pp.903~935 (2019)
75. van Mierlo, G., "The complexity of PRC2 subcomplexes", Trends Cell Biol, 29, pp.660~671 (2019)
76. Hua, C., "KDM6 demethylases and their roles in human cancers", Front. Oncol, 11, pp.779918~ (2021)
77. Guo, Y., "Regulation of EZH2 protein stability : new mechanisms, roles in tumorigenesis, and roads to the clinic", eBioMedicine, 100, pp.104972~ (2024)
78. Kuser-Abali, G., "UHRF1", UBE2L6, Oncogene, pp.2023, 42[DOI]
79. Sun, Y., "Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1", EZH2 complex in pancreatic cancer, 2021, pp.12, 878~
80. Kuser-Abali, G., "UHRF1", UBE2L6, Oncogene, pp.2023, 42[DOI]
81. Li, B., "EZH2 K63-polyubiquitination affecting migration in extranodal nat ural killer", T-cell lymphoma, 2023, pp.15, 187~
82. Chang, S., "The cancer driver genes IDH1", 2, JARID1C, KDM6A : crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism, pp.Exp. Mol. Med, 2019[DOI]
83. Wang, S.-P., "A UTX-MLL4-p300 transcriptional regulatory network coordi nately shapes active enhancer landscapes for eliciting transcription", Mol. cell, 67, pp.308~321 (2017)
84. Tie, F., "Histone deme thylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27", Mol. Cell. Biol, 32, pp.2323~2334 (2012)
85. Chen, Y. -H., "Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection : a case control study", BMC Cancer, 21, pp.1~14 (2021)
86. Van der Meulen, J., "The H3K27me3 deme thylase UTX in normal development and disease", Epigenetics, 9, pp.658~668 (2014)
87. Luo, D., "CUL4B-DDB1-COP1-mediated UTX downregulation promotes col orectal cancer progression", Exp. Hematol. Oncol, 12, pp.77~ (2023)
88. Lam, U. T. F., "Structural and functional specificity of H3K36 methylation", Epigenetics Chromatin, 15, pp.17~ (2022)
89. Wagner, E. J., "Understanding the language of Lys36 methy lation at histone H3", Nat. Rev. Mol. Cell Biol, 13, pp.115~126 (2012)
90. Tsukada, Y., "Histone demethylation by a family of JmjC domain-containing proteins", Nature, 439, pp.811~816 (2006)
91. Whetstine, J. R., "Reversal of histone lysine trimethylation by the JMJD2family of histone demethylases", Cell, 125, pp.467~481 (2006)
92. Fodor, B. D., "Jmjd2b antagonizes H3K9 trimethylation at pericentric het erochromatin in mammalian cells", Genes Dev, 20, pp.1557~1562 (2006)
93. Azagra, A., "NSD2 as a promising target in hematological disorders", Int. J. Mol. Sci, 23, pp.11075~ (2022)
94. Xiao, C., "H3K36 trimethylation-mediated biological functions in cancer", Clin. Epigenetics, 13, pp.199~ (2021)
95. Li, N., "AKT-mediated stabilization of histone methyltransferase WHSC1promotes prostate cancer metastasis", J. Clin. Invest, 127, pp.1284~1302 (2017)
96. Lv, N., "PP2Cdelta controls the differentiation and function of dendritic cells through regulating the NSD2", mTORC2, Front. Immunol, pp.2021, 12[DOI]
97. Jiang, H., "Posttranslational modification of Aurora A-NSD2 loop contributes to drug resistance in t(4;14)multiple myeloma", Clin. Transl. Med, 12, pp.e744~ (2022)
98. Park, J. W., "Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation", Commun. Biol, 3, pp.462~ (2020)
99. Campos-Sanchez, E., "Wolf-Hirschhorn syndrome candidate 1 is necessary for correct hematopoietic and B cell development", Cell Rep, 19, pp.1586~1601 (2017)
100. Ritchie, F. D., "The role of histone methyltransferases in neu rocognitive disorders associated with brain size abnormalities", Front. Neurosci, 17, pp.989109~ (2023)
101. Tommasi, S., "BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy", Mutat Res, 578, pp.395~405 (2005)
102. Luco, R. F., "Regulation of alternative splicing by histone modifications", Science, 327, pp.996~1000 (2010)
103. Li, F., "The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSalpha", Cell, 153, pp.590~600 (2013)
104. Zhu, K., "SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing", Nucleic Acids Res, 45, pp.92~105 (2017)
105. Bhattacharya, S., "Elevated levels of the methyltransferase SETD2 causes transcription and alternative splicing changes resulting in oncogenic phenotypes", Front. Cell Dev Biol, 10, pp.945668~ (2022)
106. Bhattacharya, S., "Regulation of SETD2 stability is important for the fidelity of H3K36me3 deposition", Epigenetics Chromatin, 13, pp.40~ (2020)
107. Alexandrova, E., "Histone methyltransferase DOT1L as a promising epige netic target for treatment of solid tumors", Front. Genet, 13, pp.864612~ (2022)
108. Sarno, F., "DOT1L : a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment", Epigenetics, 15, pp.439~453 (2020)
109. Liu, C., "CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis", Theranostics, 10, pp.1758~1776 (2020)
110. Song, T., "DOT1L O-GlcNAcylation promotes its protein stability and MLL fusion leukemia cell proliferation", Cell Rep, 36, pp.109739~ (2021)
111. Agredo, A., "Histone 4 lysine 20 tri-methylation : a key epigenetic regulator in chromatin structure and disease", Front. Genet, 14, pp.1243395~ (2023)
112. Jorgensen, S., "Histone H4 lysine 20 methylation : key player in epigenetic regulation of genomic integrity", Nucleic Acids Res, 41, pp.2797~2806 (2013)
113. Liu, W., "PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression", Nature, 466, pp.508~512 (2010)
114. Stender, J. D., "Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20", Mol. Cell, 48, pp.28~38 (2012)
115. Wang, J., "LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control", Nat. Neurosci, 18, pp.1256~1264 (2015)
116. Yin, Y., "SET8 plays a role in controlling G1", S transition by blocking lysine acetylation in histone through binding to H4N-terminal tail, 2008, pp.7, 1423~1432
117. Abbas, T., "CRL4(Cdt2)regulates cell proliferation and histone gene expression by targeting PR-Set7", Set8 for degradation, 2010, pp.40, 9~21
118. Centore, R. C., "CRL4(Cdt2)-mediated destruction of the histone methyl transferase Set8 prevents premature chromatin compaction in S phase", Mol. Cell, 40, pp.22~33 (2010)
119. Wu, S., "Dynamic regulation of the PR-Set7 histone methyltransferase is required for normal cell cycle progression", Genes Dev, 24, pp.2531~2542 (2010)
120. Esteve, P. O., "Poly ADP-ribosylation of SET8 leads to aberrant H4K20methylation in mammalian nuclear genome", Commun. Biol, 5, pp.1292~ (2022)
121. Boulon, S., "The nucleolus under stress", Mol. Cell, 40, pp.216~227 (2010)
122. Grummt, I., "The nucleolus-guardian of cellular homeostasis and genome integ rity", Chromosoma, 122, pp.487~497 (2013)
123. Bierhoff, H., "Noncoding transcripts in sense and antisense orientation regulate the epigenetic state of ribosomal RNA genes", Cold Spring Harb. Symp. Quant. Biol, 75, pp.357~364 (2010)
124. Bierhoff, H., "Quiescence-induced LncRNAs trigger H4K20 trimethylation and transcriptional silencing", Mol. Cell, 54, pp.675~682 (2014)
125. Zhao, Z., "lncRNA-induced nucleosome repositioning reinforces transcriptional repression of rRNA genes upon hypo tonic stress", Cell Rep, 14, pp.1876~1882 (2016)
126. Békés, M., "PROTAC targeted protein degraders : the past is prologue", Nat. Rev. Drug Discov, 21, pp.181~200 (2022)
127. Dai, X. -J., "Degraders in epigenetic therapy : PROTACs and beyond", Ther anostics, 14, pp.1464~ (2024)
128. Hsia, O., "Targeted protein degradation via intramolecular bivalent glues", Nature, 627, pp.204~211 (2024)
129. Kim, K. H., "SWI", SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2, 2015, pp.21, 1491~1496
130. Hoshii, T., "A non-catalytic function of SETD1A regulates Cyclin K and the DNA damage response", Cell, 172, pp.1007~1021 (2018)
131. Gu, F., "Biological roles of LSD1 beyond its demethylase activity", Cell Mol. Life Sci, 77, pp.3341~3350 (2020)

관련 논문AI추천